Furthermore, aberrant expression of erasers was also detected, and both FTO and ALKBH5 were significantly decreased in women with endometrial adenocarcinoma versus controls (Figure 1A). This evidence concerns the gene ALKBH5 and endometrium adenocarcinoma.